Aurora Cannabis Inc. ACB
5.05 USD -0.06 (-1.17%)
At closeNov 11, 2026, 7:58 PM EST
5.05 0.00 0.00%
After hours · Nov 11, 7:58 PM ET
5.05 Day range 5.10
2.56 52-week range 6.36
- YTD
- +19.67%
- 1 year
- +10.99%
News
fool.com The Big Winner From the Aurora Cannabis-Organigram Deal: Curaleaf Organigram is acquiring Aurora Cannabis. Curaleaf previously made multiple attempts to acquire Aurora in a hostile takeover.
zacks.com Aurora Cannabis Inc. (ACB) Q2 Earnings and Revenues Top Estimates Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.03 per share. This compares to earnings of $0.09 per share a year…
benzinga.com Aurora Cannabis Q2 EPS $(0.32) Misses $(0.09) Estimate, Sales $86.021M Beat $72.167M Estimate Aurora Cannabis (TSX:ACB) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.09) by 255.56 percent. This is a 33.33 percent increase over losses of…
businesswire.com Aurora Cannabis Announces Fiscal 2027 Second Quarter Results EDMONTON, Alberta--(BUSINESS WIRE)--Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ | TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and…
zacks.com Aurora Cannabis Stock: What Organigram's Buyout Means for Investors Aurora Cannabis shares surged after Organigram agreed to a C$561 million buyout, but competing bids, deal conditions and shareholder uncertainty remain.
prnewswire.com Curaleaf Issues Statement Regarding Alternative Proposal for Aurora Cannabis STAMFORD, Conn., Nov. 3, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf"), a leading international provider of consumer and medical cannabis products, today…
benzinga.com Aurora Cannabis Stock Surges on Organigram Deal Aurora Cannabis Inc (NASDAQ:ACB) shares are booming Tuesday after the company agreed to be acquired by Organigram Global for 7.80 Canadian dollars ($5.57) per share, a deal that tops a rival hostile…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers Curis (NASDAQ:CRIS) stock increased by 25.6% to $0.83 during Tuesday's regular session. The company's market cap stands at $1.6 million. Pasithea Therapeutics (NASDAQ:KTTA) shares increased…
gurufocus.com Organigram to Acquire Aurora and Establish a Global Cannabis Leader Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (âOrganigramâ) and Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) (âAuroraâ) today announced that they ha
benzinga.com Organigram To Acquire Aurora Cannabis For C$561 Million, Or C$7.80 Per Share Organigram to acquire Aurora for C$7.80 per Aurora Common Share; Aurora shareholders will have the option to receive such Consideration in cash, Organigram shares or a combination of both, subject to…
businesswire.com Organigram to Acquire Aurora and Establish a Global Cannabis Leader TORONTO & EDMONTON, Alberta--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (“Organigram”) and Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) (“Aurora”) today announced that they…
proactiveinvestors.com Organigram outbids Curaleaf with C$561M deal for Aurora Cannabis OrganiGram Holdings (TSX-V:OGI, NASDAQ:OGI) has agreed to acquire Aurora Cannabis Inc (TSX:ACB, NASDAQ:ACB) for C$561 million, topping a hostile takeover...
proactiveinvestors.com Sigma Lithium upsizes convertible bond offering to $125 million Sigma Lithium Corp (TSX-V:SGML, NASDAQ:SGML, ASX:SAU) has priced an upsized US$125 million convertible bond offering to refinance its senior secured debt...
businesswire.com Aurora Cannabis to Host Second Quarter 2027 Investor Conference Call EDMONTON, Alberta--(BUSINESS WIRE)--Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it will…
zacks.com ACB's Q2 Earnings on Deck: International Medical Cannabis in Focus Aurora Cannabis heads into Q2 earnings with revenues expected to fall 20.1%, as market exits and reimbursement cuts weigh on results while international medical cannabis markets offer support.
benzinga.com Alberta Securities Commission Dismisses Curaleaf Holdings's Application To Halt Aurora Cannabis' February At-The-Market Program Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, today shared that the application made by Curaleaf Holdings, Inc.
prnewswire.com Aurora Cannabis Announces the Alberta Securities Commission has dismissed Curaleaf's Application and ruled in favour of the Company's At-the-Market Program NASDAQ | TSX: ACB Alberta Securities Commission dismisses Curaleaf's application concerning Aurora's ATM program. Curaleaf's unsuccessful application before the Alberta Securities Commission confirms…
marketbeat.com Aurora Rejects Curaleaf's Higher Bid, But the Takeover Fight Isn't Over Curaleaf TodayCURLFCuraleaf$7.80 +0.17 (+2.26%) As of 02:38 PM Eastern52-Week Range$5.40▼$15.15Price Target$6.00Add to WatchlistCuraleaf Holdings, Inc. OTCMKTS: CURLF is aggressively maneuvering to…
benzinga.com Curaleaf Demands Engagement From Aurora Amid Fierce Acquisition Dispute Curaleaf condemns Aurora Cannabis for rejecting its enhanced proposal, accusing the board of obstructing engagement and fair value.
benzinga.com Curaleaf Cites Aurora Board's Fiduciary Duty Regarding Previously Recommended Shareholder Rejection Of Curaleaf's Enhanced Proposal Curaleaf Holdings, Inc. (TSX:CURA) (OTCQX:CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer and medical cannabis products, today responded to Aurora Cannabis Inc.'s
benzinga.com Aurora Cannabis' Board Recommends Shareholders Reject Offer By Curaleaf Holdings Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX:ACB) (NASDAQ:ACB), the Canadian-based leading global medical cannabis company, today reconfirms that the Board of Directors (the "Board"), on
prnewswire.com Aurora Cannabis Reaffirms Recommendation to Shareholders: REJECT Curaleaf's Revised Hostile Bid; Preserve Opportunities for Future Upside NASDAQ | TSX: ACB Revised Hostile Bid continues to significantly undervalue Aurora; fails to address concerns previously raised by the Board. Aurora's Special Committee is actively exploring…
fool.com Aurora Cannabis Stock Has Soared 25% Since Curaleaf First Made an Offer to Buy Its Business. Here's Why I Think It Can Go Even Higher Curaleaf recently raised its offer for Aurora Cannabis to $5. Aurora is reviewing the bid and will make a recommendation to shareholders on what to do.
defenseworld.net Comparing Aurora Cannabis (NASDAQ:ACB) & BeOne Medicines (NASDAQ:ONC) BeOne Medicines (NASDAQ: ONC - Get Free Report) and Aurora Cannabis (NASDAQ: ACB - Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two…
247wallst.com Tilray Brands Sinks 4% as Record Revenue Masks Shrinking Cannabis Sales; Canopy Growth and Aurora Cannabis Ease A Q1 FY2027 revenue record from Tilray Brands (NASDAQ:TLRY) is drawing heavy selling, because the segment that built the company's following moved the wrong way. Tilray Brands shares are at $3.- benzinga.com Aurora Cannabis Completes Major Expansion Of Its Facility In Leuna, Germany Multi-million-dollar investment results in increased domestic production capacity in Germany, more than doubling expected annual flower output.Enhanced facility adopts Aurora's proven cultivation…
prnewswire.com Aurora Completes Major Expansion of European EU-GMP Manufacturing Facility, More Than Doubling Expected Annual Flower Output NASDAQ | TSX: ACB Multi-million-dollar investment results in increased domestic production capacity in Germany, more than doubling expected annual flower output. Enhanced facility adopts Aurora's…- benzinga.com Aurora Cannabis Shareholders Urged For No Action Against Curaleaf's Hostile Acquisition Offer Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NASDAQ: ACB), the Canadian-based leading global medical cannabis company, responded today to a press release issued by Curaleaf Holdings,…
prnewswire.com Aurora Urges Shareholders to Take No Action to Revised Hostile Bid by Curaleaf as Formal Review Underway Aurora's Special Committee will commence a thorough and independent review of the revised Hostile Bid and the Board will provide a formal recommendation to shareholders once the review is complete.…
marketbeat.com Curaleaf's Higher Aurora Bid Raises the Stakes in Cannabis Consolidation The multi-year cannabis sector bear market is starting to give way to a calculated wave of industry consolidation. Behind the urge to merge is a significant shift in U.S. federal regulatory policy,…
benzinga.com 'DEA Judge Pauses Marijuana Rescheduling Hearing As Opponents Highlight Government Report Detailing ‘Gaps’ In Federal Processes'- Marijuana Moment https://www.marijuanamoment.net/dea-judge-pauses-marijuana-rescheduling-hearing-as-opponents-highlight-government-report-detailing-gaps-in-federal-processes/- benzinga.com Aurora Cannabis Re-Affirms FY27 Q2 Guidance For Sequential Growth In Quarterly Net Revenue And Adjusted EBITDA Re-affirms FY27 Q2 guidance for sequential growth in quarterly net revenue and adjusted EBITDA1Following the receipt of EU-GMP certification in July, Safari Flower Company is expected to contribute…
- benzinga.com Curaleaf Pens Letter To Aurora Cannabis Shareholders Urging Acceptance Of Its Takeover Offer In a letter released today, Chairman and CEO Boris Jordan encouraged Aurora shareholders to review the facts and carefully consider the alternatives available to them.Curaleaf Holdings, Inc.…
benzinga.com Aurora Cannabis Fires Back at Curaleaf’s Hostile Takeover Bid Aurora Cannabis urges shareholders to reject Curaleaf's unsolicited hostile bid, calling the offer undervaluation with serious risks.
benzinga.com Aurora Cannabis Urged Shareholders To Reject A Merger Bid From Curaleaf, Warning That The Hostile Bid Would Put Aurora Shareholders' Value And Future Upside At Risk Curaleaf's hostile and opportunistic bid significantly undervalues Aurora, and aims to capture Aurora's assets at a discountAurora is debt free and holds $149 million in cash1, Curaleaf carries over…- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers Neuronetics (NASDAQ:STIM) shares moved upwards by 34.1% to $2.91 during Tuesday's regular session. The market value of their outstanding shares is at $151.0 million. As per the press release,…
benzinga.com Curaleaf Goes Public with Premium Acquisition Proposal for Aurora Cannabis Curaleaf proposes to acquire Aurora Cannabis for $4 per share, offering a 45% premium to expand global operations.
benzinga.com Curaleaf Proposes $4.00/Share Offer For Aurora Cannabis Proposed Offer reflects a 45% premium to Aurora's 30-day VWAP and a 110% premium to Aurora's 30-day VWAP excluding balance sheet cash Provides Aurora shareholders with the opportunity to become…- benzinga.com Aurora Cannabis Q1 EPS $(0.05) Beats $(0.13) Estimate, Sales $48.798M Miss $50.510M Estimate Aurora Cannabis (NASDAQ:ACB) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.13) by 61.54 percent. This is a 73.68 percent increase over losses of…
- benzinga.com Full Transcript: Aurora Cannabis Q4 2026 Earnings Call
benzinga.com Aurora Cannabis Q4 EPS $(0.35) Misses $(0.07) Estimate, Sales $61.842M Beat $55.290M Estimate Aurora Cannabis (NASDAQ:ACB) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.07) by 400 percent. This is a 45.83 percent decrease over losses of…
benzinga.com Earnings Scheduled For June 11, 2026 - benzinga.com 'White House Pushes Congress To Keep Hemp CBD Products Legal By Amending Broad Ban That's Set To Take Effect Later This Year' - Marijuana Moment https://www.marijuanamoment.net/white-house-pushes-congress-to-keep-hemp-cbd-products-legal-by-amending-broad-ban-thats-set-to-take-effect-later-this-year/
- benzinga.com "Marijuana Components Have 'Consistent' Anti-Tumor Effects In Glioblastoma And Other Cancers, Scientific Review Shows" - Marijuana Moment https://www.marijuanamoment.net/marijuana-components-have-consistent-anti-tumor-effec
benzinga.com Aurora Cannabis Receives Plant Breeders' Rights In Canada For Two Proprietary Cannabis Cultivars This certification gives Aurora the exclusive rights to grow, propagate, and sell finished products produced from these varieties.The two protected cultivars, SOT20R07-007 (known as Farm Gas™) and…- benzinga.com Aurora Cannabis Launches Newly Expanded Lineup, Including Dried Flower, Pre‑Rolls And Pastilles Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian‑based leading global medical cannabis company, is significantly expanding its global medical cannabis portfolio, with new product launches…
- benzinga.com 'Trump Reclassifies State-Licensed Medical Marijuana As A Less-Dangerous Drug In A Historic Shift' - AP News https://apnews.com/article/medical-marijuana-rescheduling-justice-department-trump-cannabis-1d6722d3aae122b1a91f8e4b6c690268
- benzinga.com 'Trump Administration Is Expected To Move To Reclassify Marijuana As Soon As Wednesday' - Axios https://www.axios.com/2026/04/22/trump-marijuana-rule-change
- benzinga.com 'White House Schedules Meeting On Cannabis Products Enforcement Policy For Next Week'- Marijuana Moment https://www.marijuanamoment.net/white-house-schedules-meeting-on-cannabis-products-enforcement-policy-for-next-week/
- benzinga.com 'Marijuana Businesses Could List On US Stock Exchanges Like Nasdaq And NYSE Under New Bipartisan Congressional Bill' - Marijuana Moment https://www.marijuanamoment.net/marijuana-businesses-could-list-on-us-stock-exchanges-like-nasdaq-and-nyse-under-new-bipartisan-congressional-bill/